Honor. Unite. Inspire. These are the three pillars of World Lung Cancer Day (WLCD) established by the American College of Chest Physicians, in partnership with the Forum of International Respiratory Societies. To commemorate WLCD, we’re exploring the global impact of lung cancer and the promise that innovative treatments provide to patients and their loved ones.
Have a look at the staggering figures:
- More than one and a half million people around the world die from lung cancer each year—that’s more than 4,000 people per day.
- In the U.S., lung cancer is the second most common cancer among both men and women, and also the leading cause of all cancer-related deaths.
- In 2017 alone, it’s estimated that 222,500 people will receive a new lung cancer diagnosis.
- Like most cancers, lung cancer does not discriminate against race or ethnicity—all populations feel the impact.
While these numbers are serious, there is hope.
More than 430,000 people alive today have been diagnosed with lung cancer at some point during their lifetime. Advancements in cancer research, focused on immunotherapy and personalized medicine, have resulted in new treatments helping to keep people in the fight against cancer—and win. People like Bill Nack reap the benefits of these innovative treatments every day, able to return to the life they once led before the diagnosis. Further cancer research and clinical trials will continue to drive progress in lung cancer treatment and perhaps, one day, a cure.
Awareness events like WLCD help to educate while setting the stage for evaluating current and future progress in treatment options. So today, we celebrate a bright future for cancer research and the millions of lives that could be positively impacted by innovative medicines.
Want to be part of the social conversation? Follow and join the discussion by using #WorldLungCancerDay on Twitter and Facebook.